1. Home
  2. Live Updates
  3. Ono pharmaceutical co ltd

Live Breaking News & Updates on Ono pharmaceutical co ltd

Stay informed with the latest breaking news from Ono pharmaceutical co ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ono pharmaceutical co ltd and stay connected to the pulse of your community

Ono Pharmaceutical : Enters into a Collaboration Agreement with PRISM BioLab to Generate Novel Drug Candidates in the Oncology Area

 Osaka, Japan, April 25, 2024 - Ono Pharmaceutical Co., Ltd. today announced that it has entered into a drug discovery collaboration agreement with PRISM BioLab to generate novel...

Osaka , Japan , Kanagawa , Fukushima , Dai-takehara , Seishi-katsumata , Toichi-takino , Ono-pharmaceutical-co-ltd , Ono-pharmaceuticals , Biolab-head-office , Discovery-research-of-ono , Head-office

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono

Tokyo , Japan , Osaka , Japanese , Dai-takehara , Seishi-katsumata , Eisai-co-ltd , Ono-pharmaceutical-co-ltd , Biolab-co-ltd , Discovery-research-of-ono , Ohara-pharmaceuticals-co-ltd , Executive-director

Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Down 3.6%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s stock price traded down 3.6% on Friday . The stock traded as low as $16.04 and last traded at $16.04. 603 shares traded hands during trading, a decline of 87% from the average session volume of 4,726 shares. The stock had previously closed at $16.64. Ono […]

Ono-pharmaceutical-company-profile , Ono-pharmaceutical-co-ltd , Get-free-report , Pharmaceutical-trading-down , Opdivo-intravenous-infusion , Kyprolis-intravenous-injection , Ono-pharmaceutical-daily , Ono-pharmaceutical , Otcmkts-ophlf , Ophlf , Medical

Ono Pharmaceutical : Announcement on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers -April 05, 2024 at 12:07 am EDT

　Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the...

Japan , Osaka , Shusaku-nagae , Seishi-katsumata , Hiromu-habashita , Toshihiro-tsujinaka , Shinji-takai , Takehiro-yamada , Toichi-takino , Akira-takada , Hirokazu-kitada , Masaki-ito

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Australia , New-zealand , Equillium-inc , Compensation-committee , Biocon , Compensation-committee-of-equillium-board-directors , Ono-pharmaceutical-co-ltd , Exchange-commission , Nasdaq , Nasdaq-listing-rule , Biocon-limited

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia , New-zealand , Maple-fung , Ono-pharmaceutical-co-ltd , Medicines-partnership , Equillium-inc , European-league-against-rheumatism , Biocon , European-renal-association , Lupus-network , Nasdaq , Ono-pharmaceutical

Ono Pharmaceutical : Announces Completion of Cancellation of Treasury Stock -March 29, 2024 at 02:10 am EDT

　 Osaka, Japan, March 29, 2024 - Ono Pharmaceutical Co., Ltd. today announced that, as resolved by documents instead of resolution by board meetings on July 25, 2023, it...

Japan , Osaka , Gyo-sagara , Companies-act-on , Ono-pharmaceutical-co-ltd , Companies-act , Markets ,

ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL

/PRNewswire/ -- ONO Pharmaceuticals, Co., Ltd. today announced it has completed target patient enrollment of the first arm (Part A) of the PROSPECT Study, a...

Osaka , Japan , United-states , Taiwan , South-korea , Japanese , Kiyoaki-idemitsu , Kunihiko-ito , Co-ltd , Ono-pharmaceutical-co-ltd , Pharma-united-states-inc , Clinical-development

ONO PHARMA Announces Enrollment Is Complete For The First Arm Of The PROSPECT Study Of Tirabrutinib In U.S. Patients With Relapsed Or Refractory PCNSL

ONO PHARMA Announces Enrollment Is Complete For The First Arm Of The PROSPECT Study Of Tirabrutinib In U.S. Patients With Relapsed Or Refractory PCNSL
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , South-korea , Taiwan , Osaka , Japanese , Kiyoaki-idemitsu , Kunihiko-ito , Pharma-united-states-inc , Ono-pharmaceutical-co-ltd , Co-ltd , Clinical-development

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

$40.9 million cash balance at the end of 2023 expected to provide cash runway into 2H 2025


Completed enrollment of Phase 2 clinical study of EQ101 in alopecia areata: topline data expected in Q2...

New-zealand , Japan , Australia , Japanese , Steve-connelly , Arash-mostaghimi , Harvard-medical-school , Nasdaq , Equillium-inc , Exchange-commission , Ono-pharmaceutical-co-ltd , Bioniz-therapeutics-inc